Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Junia Pharma
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Junia Pharma
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
it
en
18 July 2018
PHARMANUTRA: GROWTH IN BUSINESS AND VALUE ONE YEAR FROM LISTING ON THE STOCK EXCHANGE
11 July 2018
ULTRAMAG: SUCROSOMIAL TECHNOLOGY REVOLUTIONISES THE MAGNESIUM MARKET
05 July 2018
PHARMANUTRA TAKES CENTRE STAGE AT THE “HEALTHCARE FORUM” AT THE BORSA ITALIANA
04 July 2018
PHARMANUTRA PARTICIPATES IN THE “HEALTH CARE FORUM” IN BORSA ITALIANA
03 July 2018
PHARMANUTRA: FRANCESCO SARTI APPOINTED CHIEF FINANCIAL OFFICER OF THE GROUP
28 June 2018
PHARMANUTRA: NEW SALES RECORD IN MAY
28 May 2018
NEW COMMERCIAL AGREEMENTS SIGNED FOR THE DISTRIBUTION OF SUCROSOMIAL® IRON ABROAD
23 April 2018
PHARMANUTRA: SHAREHOLDERS’ MEETING OF 23 APRIL 2018
11 April 2018
6TH INTERNATIONAL MULTIDISCIPLINARY COURSE ON IRON DEFICIENCY (IMCID)
06 April 2018
PHARMANUTRA OBTAINS A PATENT FOR CETILAR® RM
27 March 2018
PHARMANUTRA: SUCROSOMIAL® IRON CHOSEN AS PRODUCT OF THE YEAR BY ISRAELI CONSUMERS
20 March 2018
PHARMANUTRA: THE BOARD OF DIRECTORS APPROVES THE DRAFT SEPARATE AND CONSOLIDATED FINANCIAL STATEMENTS AS OF AND FOR THE YEAR ENDED 31 DECEMBER 2017
<
1
…
15
16
17
18
>